| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 79 |
| 1 | ALBUTEROL SULFATE | 51 |
| 2 | METHOTREXATE SODIUM | 50 |
| 3 | PREDNISOLONE | 45 |
| 4 | PREDNISOLONE ORAL | 45 |
| 5 | PREDNISOLONE ORAL SOLUTION | 45 |
| 6 | METHOTREXATE | 43 |
| 7 | ERGOCALCIFEROL | 35 |
| 8 | CYCLOPHOSPHAMIDE | 34 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORBITOL | 3 | 0.0050 |
| 1 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 2 | BARICITINIB | 10 | 0.0033 |
| 3 | ROFLUMILAST | 20 | 0.0028 |
| 4 | BERACTANT | 1 | 0.0027 |
| 5 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 6 | ACLIDINIUM BROMIDE | 15 | 0.0023 |
| 7 | NITROFURANTOIN (MACROCRYSTALS) | 1 | 0.0016 |
| 8 | SILTUXIMAB | 1 | 0.0015 |
| 9 | CALCIUM FOLINATE | 7 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 166 |
| 1 | Alkylating Drug [EPC] | 47 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 46 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 4 | Platinum-based Drug [EPC] | 38 |
| 5 | Osmotic Laxative [EPC] | 34 |
| 6 | Antirheumatic Agent [EPC] | 28 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 27 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 27 |
| 9 | Microtubule Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 14 | 0.0011 |
| 2 | Actinomycin [EPC] | 2 | 0.0009 |
| 3 | Surfactant [EPC] | 1 | 0.0009 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 5 | 0.0008 |
| 5 | Interferon gamma [EPC] | 1 | 0.0007 |
| 6 | Pyrethroid [EPC] | 1 | 0.0006 |
| 7 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 8 | 0.0005 |
| 9 | Antimycobacterial [EPC] | 10 | 0.0004 |